tiprankstipranks
Trending News
More News >
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
30d ago
Plus Therapeutics appoints Kyle Guse to board of directors
Premium
The Fly
Plus Therapeutics appoints Kyle Guse to board of directors
1M ago
Plus Therapeutics Appoints Kyle Guse to Board
Premium
Company Announcements
Plus Therapeutics Appoints Kyle Guse to Board
1M ago
Plus Therapeutics’ Optimistic Earnings Call Highlights
PremiumCompany AnnouncementsPlus Therapeutics’ Optimistic Earnings Call Highlights
2M ago
Promising Outlook for Plus Therapeutics: Strategic Financial Moves and Innovative Assay Launch Justify Buy Rating
Premium
Ratings
Promising Outlook for Plus Therapeutics: Strategic Financial Moves and Innovative Assay Launch Justify Buy Rating
2M ago
Plus Therapeutics price target lowered to $5.50 from $8 at H.C. Wainwright
Premium
The Fly
Plus Therapeutics price target lowered to $5.50 from $8 at H.C. Wainwright
2M ago
Plus regains compliance with Nasdaq minimum stockholders’ equity requirement
PremiumThe FlyPlus regains compliance with Nasdaq minimum stockholders’ equity requirement
3M ago
Plus Therapeutics announces publication of results on 186Re Obisbemeda
Premium
The Fly
Plus Therapeutics announces publication of results on 186Re Obisbemeda
3M ago
Plus Therapeutics granted Orphan Drug Designation for Rhenium Obisbemeda
Premium
The Fly
Plus Therapeutics granted Orphan Drug Designation for Rhenium Obisbemeda
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100